Panic Disorder

• FDA approval · 2013-09-26
  FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

  FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by Roerig.

• FDA approval · 2013-09-19
  FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved the supplemental application for Alprazolam from Aurobindo Pharma Limited (generic alprazolam). The approval pertains to a supp…

• FDA approval · 2013-07-26
  FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for clonazepam filed by Par Health USA, LLC.

• FDA approval · 2013-06-28
  FDA Approved: PAROXETINE — Original Application (Padagis US LLC)

  FDA approved a paroxetine product from Padagis US LLC under an original application.

• FDA approval · 2013-05-31
  FDA Approved: CLONAZEPAM — Supplemental Application (Advagen Pharma Ltd)

  FDA approved Advagen Pharma Ltd's supplemental application for clonazepam (generic) under ANDA075468, authorizing an additional clonazepam p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-02-01
  FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

  FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG.

• FDA approval · 2013-01-29
  FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., indicating approval of changes to th…

• FDA approval · 2013-01-28
  FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for clonazepam from Teva Pharmaceuticals USA, Inc.

• FDA approval · 2013-01-03
  FDA Approved: PROZAC — Supplemental Application (Dista Products Company)

  The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.

• FDA approval · 2012-12-21
  FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  FDA approved a supplemental application for sertraline hydrochloride by Quallent Pharmaceuticals Health LLC.

• FDA approval · 2012-12-18
  FDA Approved: PAXIL — Supplemental Application (Apotex Corp)

  The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.

• FDA approval · 2012-12-18
  FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

  The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.

• FDA approval · 2012-12-11
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)

  The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, expanding the drug’s approved …

• FDA approval · 2012-11-29
  FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for alprazolam from Sandoz Inc under an Abbreviated New Drug Application, resulting in an approved a…

• FDA approval · 2012-11-29
  FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

  The FDA approved a supplemental application for Alprazolam by Sandoz Inc, a generic benzodiazepine used to treat anxiety disorders such as g…

• FDA approval · 2012-10-25
  FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for clonazepam from Aurobindo Pharma Limited under an ANDA, confirming continued availability of thi…

• FDA approval · 2012-10-01
  FDA Approved: FLUOXETINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved the original (ANDA) application for fluoxetine from Heritage Pharmaceuticals (d/b/a Avet), confirming a generic formulation of …

• FDA approval · 2012-09-27
  FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, allowing the generic product to be marketed under the …

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)

  FDA approval of a supplemental application for venlafaxine from BluePoint Laboratories (ANDA).

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, resulting in approval of a generic venl…

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to t…

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)

  FDA approved a supplemental application for venlafaxine hydrochloride submitted by Dr. Reddy's Laboratories Limited.

• FDA approval · 2012-09-19
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc.

• FDA approval · 2012-07-31
  FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

  FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings (PAI Pharma), confirming approval of a generic fluoxe…